Abstract
This is an illustrative case of a patient with neuroleptic malignant syndrome whom we believe is the first described in the world's literature to have this syndrome on three occasions, each time after having received a different neuroleptic agent.
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects*
-
Chlorpromazine / adverse effects
-
Female
-
Haloperidol / adverse effects
-
Humans
-
Neuroleptic Malignant Syndrome / etiology*
-
Trifluoperazine / adverse effects
Substances
-
Antipsychotic Agents
-
Trifluoperazine
-
Haloperidol
-
Chlorpromazine